Related Experiment Video
Updated: Feb 27, 2026

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
Published on: March 28, 2021
Complete response to temozolomide in chronic lymphocytic leukemia
Archana Rao1, Nisha Ramani2, Robert Stoppacher2
1Hematology Oncology Associates of CNY 5008 Brittonfield Parkway East Syracuse 13057 New York.
Abstract:
We report a case of incidentally diagnosed chronic lymphocytic leukemia (CLL) in a patient with glioblastoma, which responded completely following standard treatment of the glioblastoma with temozolomide and cranial irradiation. The patient remained without an evidence of CLL until his death from recurrent glioblastoma. Further study of temozolomide for the treatment of CLL is indicated.
Related Concept Videos
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...

